You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Claims for Patent: 12,162,865

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 12,162,865

Title:	Methods of treating cancer
Abstract:	The present invention relates to methods of treating cancer by administering the EZH2 inhibitor compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.
Inventor(s):	Sarah K. Knutson, Natalie Warholic, Heike Keilhack
Assignee:	Epizyme Inc
Application Number:	US17/689,704
Patent Claims:	1. A method of treating a human subject comprising administering to the human subject a compound: or a pharmaceutically acceptable salt thereof; wherein the human subject has reduced expression or loss of function of INI1 and epithelioid sarcoma. 2. The method of claim 1, wherein the pharmaceutically acceptable salt is a hydrobromic acid salt. 3. The method of claim 1, wherein the human subject has reduced expression of INI1. 4. The method of claim 2, wherein the human subject has reduced expression of INI1. 5. The method of claim 1, wherein the human subject has loss of function of INI1. 6. The method of claim 2, wherein the human subject has loss of function of INI1. 7. The method of claim 3, wherein reduced expression of INI1 is detected by an immunoassay. 8. The method of claim 4, wherein reduced expression of INI1 is detected by an immunoassay. 9. The method of claim 5, wherein loss of function of INI1 is determined by detecting any alteration in a nucleic acid sequence encoding INI1. 10. The method of claim 6, wherein loss of function of INI1 is determined by detecting any alteration in a nucleic acid sequence encoding INI1. 11. The method of claim 5, wherein loss of function is caused by a loss of function mutation. 12. The method of claim 6, wherein loss of function is caused by a loss of function mutation. 13. The method of claim 9, wherein loss of function is caused by a loss of function mutation. 14. The method of claim 10, wherein loss of function is caused by a loss of function mutation.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.